Clinical Pharmacy for Patients with a PICC Line (CLIPICC)

Toulouse University Hospital

Status: Completed

Conditions: Catheter Complications

Treatments: Other: Clinical pharmacy activities along the care pathways

Study type: Interventional

Funder types: Other

Identifiers

NCT04359056

2019-A02475-52 (Other Identifier)

RC31/18/0459

Details and patient eligibility

About

Clinical pharmacy is a patient-centered discipline and improves significantly the safety of drug management. Regarding medications, clinical pharmacy is efficient. The investigator hypothesize that clinical pharmacy applied to medical devices could be as effective as in the medication field.

The main objective of this study is to assess the effectiveness of clinical pharmacy activities during entire care pathways of patients implanted with a PICC line, in preventing complications.

Full description

This is a preliminary, before-after, monocentric and prospective study. The study will begin with an observational period and will be followed by an experimental intervention period. Sixty-nine adult patients in each period will be included. During the observational phase, no clinical pharmacy activities will be performed. During the interventional phase, clinical pharmacists will be active during the entire patients' care pathways.

Enrollment: 138 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patient, age equal to or older than 18 years old
• Patient capable of giving free and informed consent
• Patient insured by the Social Security System
• Patient living at home
• Patient with a PICC line prescription
• Patient whose discharge prescription should contain drugs and MDs
• Patient for home discharge implanted with a PICC line
• Patient reachable by phone

Exclusion criteria

• Under aged patient, age under 18 years old
• Uninsured patient by the Social Security System
• Patient not living at home :
• Institutionalized patient
• Patient living in a home for elderly dependent persons
• Nursing home resident
• Home-hospitalized patient
• Patient deprived of liberty by a judicial or administrative decision
• Patient under guardianship, curatorship or safeguard of justice
• Patient unreachable by phone
• Pregnant or breastfeeding women

Trial design

Primary purpose: Prevention

Allocation: Non-Randomized

Interventional model: Sequential Assignment

Masking: None (Open label)

---

138 participants in 2 patient groups

control

No Intervention group

Description:

patients for the observational phase. This corresponds to usual cares where no clinical pharmacy activities will be performed

Interventional

Experimental group

Description:

patients for the interventional phase where clinical pharmacy activities will be performed at each step of the care pathway: from hospitalization to home care.

Treatment:

Other: Clinical pharmacy activities along the care pathways